International medical technology and cybersecurity company Sectra, in collaboration with distribution partner Matsunami Glass, has commenced the implementation phase of its first digital pathology project in Japan. This milestone marks Sectra's entry into the Japanese digital pathology market and highlights the potential of its technology to advance diagnostic capabilities and support the country's evolving healthcare needs.
"Collaborating with Kameda Medical Centre for Sectra's first digital pathology project in Japan is a significant milestone for us. We are honoured to receive an order from such a respected institution and to work closely with Professor Fukuoka. This demonstrates our commitment to being a trusted partner for Japanese healthcare providers, supporting their adoption of digital pathology and enabling more efficient diagnostics to improve patient care," says Torbjörn Kronander, President and CEO of Sectra AB.
The implementation of Sectra's digital pathology module at Kameda Medical Centre follows a contract signed in the second quarter of Sectra's 2025/2026 fiscal year. The contract was sold by Sectra's distribution partner for digital pathology in Japan, Matsunami Glass.
Sectra's digital pathology solution will allow the pathologists at Kameda Medical Centre to enhance review and collaboration around cases as well as benefit from tightly integrated AI tools. The digital workflow provides instant and, when needed, remote access to digital images of tissue samples instead of relying on physical glass slides reviewed in microscopes.
"After nearly a decade of successful operation as a fully digital pathology laboratory, we are entering a new phase and have made a strategic decision to transition from a scanner-restricted workflow to a comprehensive digital pathology module. To support this evolution, we are partnering with Sectra, whose platform offers robust compatibility, interoperability, and data security," says Professor Junya Fukuoka, Chair of the Department of Pathology at Kameda Medical Centre.
